vaccine

Study: Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial. Image Credit: creativeneko/ Shutterstock

Inactivated egg-based Newcastle disease virus vaccine expressing SARS-CoV-2 spike protein

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus is the causal agent of the coronavirus disease-2019 (COVID-19) pandemic and has already claimed more than 4.73 million lives worldwide. Vaccination programs have begun in many countries, but low- and middle-income countries (LMICs) are still lacking in the availability of vaccine doses. Study: Safety and Immunogenicity of …

Inactivated egg-based Newcastle disease virus vaccine expressing SARS-CoV-2 spike protein Read More »

Researchers examine public sentiment on social media platform regarding COVID-19 vaccine

Researchers examine public sentiment on social media platform regarding COVID-19 vaccine

Credit: Pixabay/CC0 Public Domain A data analysis of public sentiment about the COVID-19 vaccine from December 2020-May 2021 on one popular social media platform by a team of researchers at the University of Tennessee Health Science Center found more positive than negative sentiment regarding the vaccine. The study led by Arash Shaban-Nejad, Ph.D., an associate …

Researchers examine public sentiment on social media platform regarding COVID-19 vaccine Read More »

Consumers get online tool to check nursing home vaccine data

Consumers get online tool to check nursing home vaccine data

In this April 26, 2021 file photo, a nursing student administers the Moderna COVID-19 vaccine at a vaccination center at UNLV, in Las Vegas. Families and patients have a new online tool to compare COVID-19 vaccination rates among nursing homes, Medicare announced Tuesday, Sept. 21, addressing complaints from consumer groups and lawmakers that the critical …

Consumers get online tool to check nursing home vaccine data Read More »

Study: COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants. Image Credit: NIAID

COVID-19 vaccine effectiveness against SARS-CoV-2 variants

A commentary published in the journal Cell summarizes international data on vaccine effectiveness against new severe acute respiratory coronavirus 2 (SARS-CoV-2) variants. Evidence shows that the currently approved vaccines continue to be effective in preventing severe and symptomatic illness — even with the widely circulating Delta variant. SARS-CoV-2 has mutated many times in the pandemic. …

COVID-19 vaccine effectiveness against SARS-CoV-2 variants Read More »

Com-COV vaccine mix-and-match study expands to 12- to 16-year-olds

Com-COV vaccine mix-and-match study expands to 12- to 16-year-olds

Credit: Pixabay/CC0 Public Domain Researchers running the University of Oxford-led Com-COV program have launched a new study of COVID-19 vaccination schedules in young people aged 12 to 16. Backed through funding from the Vaccines Taskforce and National Institute for Health Research (NIHR) and run across four NIHR-supported sites by the National Immunisation Schedule Evaluation Consortium, …

Com-COV vaccine mix-and-match study expands to 12- to 16-year-olds Read More »

Study:Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staffs with a history of allergy. Image Credit: Neeila/ Shutterstock

Medical staff with a history of allergy suffered adverse reactions to BNT162b2 COVID-19 vaccine

Scientists have claimed that the continual spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus can only be contained through rapid vaccination. SARS-CoV-2 is a positive-stranded RNA virus that has caused the coronavirus disease (2019) pandemic. Researchers worldwide worked at an unprecedented speed to develop vaccines and therapeutics to contain the ongoing pandemic. Several vaccines …

Medical staff with a history of allergy suffered adverse reactions to BNT162b2 COVID-19 vaccine Read More »

A new synthetic multiantigen MVA vaccine COH04S1 effective against SARS-CoV-2

A new synthetic multiantigen MVA vaccine COH04S1 effective against SARS-CoV-2

Scientists believe that vaccinating the entire global population is the key to contain the ongoing coronavirus disease 2019 (COVID-19) pandemic. This pandemic is caused by the rapid outbreak of a ribonucleic acid (RNA) virus known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Study: Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian …

A new synthetic multiantigen MVA vaccine COH04S1 effective against SARS-CoV-2 Read More »

Third dose of Pfizer-BioNTech vaccine increases neutralizing antibody levels against SARS-CoV-2

Third dose of Pfizer-BioNTech vaccine increases neutralizing antibody levels against SARS-CoV-2

A third dose of the Pfizer-BioNTech vaccine significantly increased neutralizing antibody levels against SARS-CoV-2, the virus that causes COVID-19, according to new research published in the New England Journal of Medicine. Pfizer, BioNTech and University of Texas Medical Branch scientists tracked the immune response of participants in clinical trials for the vaccine. They found that …

Third dose of Pfizer-BioNTech vaccine increases neutralizing antibody levels against SARS-CoV-2 Read More »

Vaccine bookings spike after Italy extends Covid pass

Bookings for coronavirus vaccines in Italy spiked this week after the government said all employees must show proof of a jab, negative test or recent recovery from Covid-19, authorities said. “On a national level, there was a generalised increase in bookings for the first dose of between 20 and 40 percent compared to last week,” …

Vaccine bookings spike after Italy extends Covid pass Read More »